{
    "title": "Addressing the Role of Obesity in Endometrial Cancer Risk, Prevention, and Treatment.",
    "doc_id": "27903150",
    "writer": "Onstad MA",
    "year": "2016",
    "summary": "In sharp contrast to many other cancer types, the incidence and mortality of endometrial cancer continue to grow. This unfortunate trend is, in no small part, a result of the worldwide obesity epidemic. ...In this review, we identify the molecular mechanisms â€¦",
    "abstract": "In sharp contrast to many other cancer types, the incidence and mortality of endometrial cancer continue to grow. This unfortunate trend is, in no small part, a result of the worldwide obesity epidemic. More than half of endometrial cancers are currently attributable to obesity, which is recognized as an independent risk factor for this disease. In this review, we identify the molecular mechanisms by which obesity and adipose tissue contribute to the pathogenesis of endometrial cancer. We further discuss the impact of obesity on the clinical management of the disease and examine the development of rational behavioral and pharmaceutical interventions aimed at reducing endometrial cancer risk, improving cancer outcomes, and preserving fertility in an increasingly younger population of patients with endometrial cancer.",
    "link": "https://pubmed.ncbi.nlm.nih.gov/27903150/",
    "clean_text": "addressing the role of obesity in endometrial cancer risk prevention and treatment in sharp contrast to many other cancer types the incidence and mortality of endometrial cancer continue to grow this unfortunate trend is in no small part a result of the worldwide obesity epidemic in this review we identify the molecular mechanisms in sharp contrast to many other cancer types the incidence and mortality of endometrial cancer continue to grow this unfortunate trend is in no small part a result of the worldwide obesity epidemic more than half of endometrial cancers are currently attributable to obesity which is recognized as an independent risk factor for this disease in this review we identify the molecular mechanisms by which obesity and adipose tissue contribute to the pathogenesis of endometrial cancer we further discuss the impact of obesity on the clinical management of the disease and examine the development of rational behavioral and pharmaceutical interventions aimed at reducing endometrial cancer risk improving cancer outcomes and preserving fertility in an increasingly younger population of patients with endometrial cancer"
}